# Cocrystal Pharma, Inc.: Form 8-K, filed Mar 13, 2026

- Company: [Cocrystal Pharma, Inc.](/companies/cocp.md) (CIK 1412486)
- Form: 8-K
- Filed: 2026-03-13
- Accepted by EDGAR: Mar 13, 2026, 16:30 ET
- Period: 2026-03-10
- Accession: 0001493152-26-010071
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1412486/000149315226010071/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1412486/000149315226010071/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1412486/000149315226010071/form8-k.htm

Filed Mar 13, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-010071. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.